FDA finally backs down with its blood pressure complaints against this wearable
AI Summary
TL;DR Last August, the FDA contacted WHOOP about concerns with its blood pressure analysis. Ever since then, the two have been working to negotiate an mutually agreeable solution. This week, the FDA has signed off on WHOOP’s new approach, incorporating some labeling changes.
Discussion
Sign in to join the discussion.
Loading comments…